The Food and Drug Administration Biologics Effectiveness and Safety Initiative Facilitates Detection of Vaccine Administrations From Unstructured Data in Medical Records Through Natural Language Processing. - Matthew Deady; Hussein Ezzeldin; Kerry Cook; Douglas Billings; Jeno Pizarro; Amalia A. Plotogea; Patrick Saunders-Hastings; Artur Belov; Barbee I. Whitaker; Steven A. Anderson (Frontiers Digit. Health, 2021)

Enhancing Biologics Adverse Event Surveillance via Scalable, FHIR-based Infrastructure: Proof of Concept. - Hussein Ezzeldin; Steven Anderson; Abhishek Pandey; Lance Jones; Aaron Walerysiak; Jay Nakashima (AMIA, 2022)

A Semi-automated Scalable Adverse Event Surveillance System. - Hussein Ezzeldin; Anna Podgornyak; Matthew Deady; Lance Jones; Jay Nakashima; Steven Anderson (AMIA, 2022)